The time is now to start molecular subtyping high-intermediate and high-risk endometrial cancers.
作者信息
Dood Robert, Trabert Britton, Werner Theresa L, Gaffney David, Jarboe Elke
机构信息
Department of Obstetrics and Gynecology, The University of Utah School of Medicine, Salt Lake City, Utah, USA
University of Utah Health Huntsman Cancer Institute, Salt Lake City, Utah, USA.
出版信息
Int J Gynecol Cancer. 2022 Aug 1;32(8):1087-1088. doi: 10.1136/ijgc-2022-003709.
Abstract
摘要
相似文献
1
The time is now to start molecular subtyping high-intermediate and high-risk endometrial cancers.现在是时候开始对高中度和高危子宫内膜癌进行分子分型了。
Int J Gynecol Cancer. 2022 Aug 1;32(8):1087-1088. doi: 10.1136/ijgc-2022-003709.
2
[Molecular-integrated risk profile: An opportunity for therapeutic de-escalation in intermediate and high-intermediate risk endometrial cancer].[分子整合风险谱：中高危子宫内膜癌治疗降阶梯的契机]
Cancer Radiother. 2022 Oct;26(6-7):931-937. doi: 10.1016/j.canrad.2022.06.007. Epub 2022 Aug 26.
3
FGFR2c Mesenchymal Isoform Expression Is Associated with Poor Prognosis and Further Refines Risk Stratification within Endometrial Cancer Molecular Subtypes.FGFR2c间充质亚型表达与子宫内膜癌预后不良相关，并进一步细化了子宫内膜癌分子亚型内的风险分层。
Clin Cancer Res. 2020 Sep 1;26(17):4569-4580. doi: 10.1158/1078-0432.CCR-19-4088. Epub 2020 May 15.
4
Comparative analysis of European guideline-based clinicopathological risk groups and the International Federation of Gynecology and Obstetrics staging system for endometrial cancer.基于欧洲指南的子宫内膜癌临床病理风险组与国际妇产科联合会分期系统的比较分析。
Eur J Obstet Gynecol Reprod Biol. 2025 Apr 17;308:85-89. doi: 10.1016/j.ejogrb.2025.02.049. Epub 2025 Feb 24.
5
Clinical relevance of high-intermediate risk endometrial cancer according to European risk classification.根据欧洲风险分类，高-中风险子宫内膜癌的临床相关性。
Int J Gynecol Cancer. 2020 Oct;30(10):1528-1534. doi: 10.1136/ijgc-2020-001693. Epub 2020 Aug 18.
6
[Application in France of the 2021 European recommendations on endometrial cancer].[2021年欧洲子宫内膜癌建议在法国的应用]
Bull Cancer. 2023 Jan;110(1):55-68. doi: 10.1016/j.bulcan.2022.11.003. Epub 2022 Nov 30.
7
Vaginal brachytherapy management of stage I and II endometrial cancer.阴道近距离放疗在 I 期和 II 期子宫内膜癌中的应用。
Int J Gynecol Cancer. 2022 Mar;32(3):304-310. doi: 10.1136/ijgc-2021-002493.
8
PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer.PORTEC-4a：基于分子谱的辅助治疗用于中高危子宫内膜癌患者的国际随机试验。
Int J Gynecol Cancer. 2020 Dec;30(12):2002-2007. doi: 10.1136/ijgc-2020-001929. Epub 2020 Oct 12.
9
Radiation-associated endometrial cancers are prognostically unfavorable tumors: a clinicopathologic comparison with 527 sporadic endometrial cancers.放射性相关子宫内膜癌是预后不良的肿瘤：与527例散发性子宫内膜癌的临床病理比较。
Gynecol Oncol. 2006 Dec;103(3):948-51. doi: 10.1016/j.ygyno.2006.05.039. Epub 2006 Jul 25.
10
RADIATION AND CHEMORADIATION THERAPY FOR I STAGE INTERMEDIATE AND HIGH/INTERMEDIATE ENDOMETRIAL CANCER - DESCRIPTIVE ANALYSIS.Ⅰ 期中高危/中危子宫内膜癌的放化疗——描述性分析。
Probl Radiac Med Radiobiol. 2021 Dec;26:554-561. doi: 10.33145/2304-8336-2021-26-554-561.
引用本文的文献
1
Molecular Classification of Endometrial Cancer and the 2023 FIGO Staging: Exploring the Challenges and Opportunities for Pathologists.子宫内膜癌的分子分类与2023年国际妇产科联盟（FIGO）分期：探讨病理学家面临的挑战与机遇
Cancers (Basel). 2023 Aug 15;15(16):4101. doi: 10.3390/cancers15164101.
2
: A Quick, Simple, and Cheap Alternative for Sequencing in Endometrial Cancer by Multiplex Genotyping Quantitative Polymerase Chain Reaction.多重基因分型定量聚合酶链反应在子宫内膜癌测序中的快速、简单、廉价的替代方法
JCO Glob Oncol. 2023 May;9:e2200384. doi: 10.1200/GO.22.00384.
本文引用的文献
1
Endometrial carcinoma molecular subtype correlates with the presence of lymph node metastases.子宫内膜癌分子亚型与淋巴结转移的存在相关。
Gynecol Oncol. 2022 May;165(2):376-384. doi: 10.1016/j.ygyno.2022.01.025. Epub 2022 Mar 2.
2
Cost-effectiveness analysis of tumor molecular classification in high-risk early-stage endometrial cancer.高危型早期子宫内膜癌肿瘤分子分类的成本效果分析。
Gynecol Oncol. 2022 Jan;164(1):129-135. doi: 10.1016/j.ygyno.2021.10.071. Epub 2021 Nov 2.
3
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.ESGO/ESTRO/ESP 子宫内膜癌管理指南。
Int J Gynecol Cancer. 2021 Jan;31(1):12-39. doi: 10.1136/ijgc-2020-002230. Epub 2020 Dec 18.
4
A clinically applicable molecular-based classification for endometrial cancers.一种适用于临床的子宫内膜癌分子分类方法。
Br J Cancer. 2015 Jul 14;113(2):299-310. doi: 10.1038/bjc.2015.190. Epub 2015 Jun 30.
Zotero 插件